Yipinhong Pharmaceutical Aims to Boost R&D With US Unit

Yipinhong Pharmaceutical Aims to Boost R&D With US Unit

Tang Shihua

Date: Mon, 04/16/2018 - 14:57 / source:Yicai
Yipinhong Pharmaceutical Aims to Boost R&D With US Unit
Yipinhong Pharmaceutical Aims to Boost R&D With US Unit

(Yicai Global) April 16 -- Chinese drugmaker Yipinhong Pharmaceutical Co. aims to boost research and development capacity overseas through the establishment of a USD5 million wholly-owned subsidiary in Delaware, US.

The new unit will lay the foundation for the company to establish a presence in the overseas pharmaceutical market, the Guangdong-based firm said in a statement.

The company plans to tap the US market for advanced product development processes and technologies, while also boosting efforts to diversify product lines and strengthen innovation.

Editor: William Clegg

Follow Yicai Global on

Keywords: U.S. Subsidiary, Pharmaceutical Company, Yipinhong Pharmacy